A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

書目詳細資料
主要作者:	Islam, Saidul
其他作者:	Sharmin, Shahana
格式:	Thesis
語言:	English
出版:	Brac University 2022
主題:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
在線閱讀:	http://hdl.handle.net/10361/17308

相似書籍

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
由: Karim, Azrin
出版: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Flora, Sanzida Alam
出版: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
由: Meem, Manila
出版: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
由: Alam, Tahera
出版: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
由: Jahan, Nusrat
出版: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
由: Ahmed, Nafisa
出版: (2023)

Immunotherapy in the Management of Lung Cancer
由: Tasnim, Humayra
出版: (2022)

A review on triple-negative breast cancer and its potential treatment
由: Niasa, Jannatul Ferdous
出版: (2023)

Stem cells as therapeutic carrier in cancer treatment
由: Anika, Mysha Yeasmin
出版: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
由: Hasan, Amit
出版: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
由: Chakraborty, Anuradha
出版: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
由: Khan, Muidul Hasan
出版: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
由: Roy, Hredita
出版: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
由: Emon, Kamrul Hasan
出版: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
由: Mirza, Maisa Tasnim
出版: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
由: Khan, Rezia Nowrin
出版: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
由: Nuha, Nabiha Tahsin
出版: (2024)

Role of statins as antagonists of SPARC in gastric cancer
由: Shahmat, Rad
出版: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
由: Sorno, Rubina Haque
出版: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
由: Ratu, Tabassum
出版: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
由: Choki, Kinley
出版: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
由: Razna, Amrin Islam
出版: (2019)

A comprehensive review on drug repurposing in cancer treatment
由: Sarkar, Onusree
出版: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
由: Mahaleka, Aarshi
出版: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
由: Shaikat, Mahdi Mubin
出版: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
由: Hasan, Sakib
出版: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
由: Nawar, Anika
出版: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
由: Deeba, Maliha Tasnim
出版: (2018)

Targeting BRAFV600E in the treatment of CRC
由: Roja, Mashwiyat Samrin
出版: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
由: Alam, Kazi Tasnuva
出版: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
由: Rahman, Sanjida
出版: (2024)

Biosimilar in lymphoma treatment
由: Tanisha, Mehrin Haque
出版: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
由: Khondokar, Faiza
出版: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
由: Islam, Nahidul
出版: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
由: Beruni, Sajid Mahmud Al
出版: (2022)

Oncogenes: new targets in cancer treatment
由: Chowdhury, Waseka Shams
出版: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
由: Muntaha, Habibatul
出版: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
由: Haque, Mushfiqul
出版: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Karim, Samia Binte
出版: (2024)